🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma Follicular › Massachusetts › Boston

Qorannoo klinikaalii Lymphoma Follicular Boston, MA keessatti

Qorannoo 17 Lymphoma Follicular f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07215910

Epco, Zanu, Ritux for R/R FL or MZL

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06563596

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Boston
  • Research Site, Boston
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06549595

NEO100 and High-Grade Meningioma

Namoota walitti qabaa jiraSadarkaa 2
  • Tufts Medical Center, Boston
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05023018

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Beth Israel Deaconess Medical Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06091254

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Namoota walitti qabaa jiraSadarkaa 3
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

Epcoritamab and Rituximab for First-line Follicular Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05783609

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Namoota walitti qabaa jiraSadarkaa 3
  • Local Institution - 0145, Boston
  • Local Institution - 0244, Boston
  • Local Institution - 0247, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06911502

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Bit-2026 · NCT06026319

Odronextamab in Low Tumor Volume Advanced FL

Namoota walitti qabaa jiraSadarkaa 2
  • Beth Israel Deaconess Medical Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT07128641

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Namoota walitti qabaa jiraSadarkaa 2
  • Beth Israel Deaconess Medical Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06510361

Study of SGR-1505 in Mature B-Cell Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Beth Israel Deaconess Medical Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ama-2026 · NCT04669171

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Namoota walitti qabaa jiraSadarkaa 2
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT06550141

Qorannoo Lymphoma Follicular magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.